Ownership history in Frazier Life Sciences Management, L.P. · 16 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in PHATHOM PHARMACEUTICALS INC (PHAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 12,466,489 | — | 0% | 5.55% | $206.8M | $16.59 |
| 2025 Q3 | UNCHANGED | 12,466,489 | — | 0% | 4.40% | $146.7M | $11.77 |
| 2025 Q2 | ADDED | 12,466,489 | +2,357,210 | +23.3% | 4.78% | $119.6M | $9.59 |
| 2025 Q1 | UNCHANGED | 10,109,279 | — | 0% | 2.90% | $63.4M | $6.27 |
| 2024 Q4 | UNCHANGED | 10,109,279 | — | 0% | 3.41% | $82.1M | $8.12 |
| 2024 Q3 | UNCHANGED | 10,109,279 | — | 0% | 7.33% | $182.8M | $18.08 |
| 2024 Q2 | UNCHANGED | 10,109,279 | — | 0% | 4.87% | $104.1M | $10.30 |
| 2024 Q1 | UNCHANGED | 10,109,279 | — | 0% | 4.53% | $107.4M | $10.62 |
| 2023 Q4 | UNCHANGED | 10,109,279 | — | 0% | 4.93% | $92.3M | $9.13 |
| 2023 Q3 | UNCHANGED | 10,109,279 | — | 0% | 6.96% | $104.8M | $10.37 |
As of 2025 Q4 — sorted by position size